CGVHD
Clinical trials for CGVHD explained in plain language.
Never miss a new study
Get alerted when new CGVHD trials appear
Sign up with your email to follow new studies for CGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients battling debilitating rejection disease
Disease control Not yet recruitingThis early-stage study is testing an experimental drug called Gecacitinib for people with chronic graft-versus-host disease (cGVHD) that doesn't improve with standard steroid treatment. The trial will first find a safe dose and then see if the drug helps control the disease and i…
Matched conditions: CGVHD
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Stanford launches rescue trial for transplant patients with Treatment-Resistant complications
Disease control Not yet recruitingThis early-stage trial is testing whether adding sarilumab can help control chronic graft-versus-host disease in adults who didn't respond well to their current treatment, belumosudil. The study will enroll 10 participants at Stanford University to first check if the combination …
Matched conditions: CGVHD
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC